Biotech

All Articles

Arch closes $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arch Endeavor Partners is...

Orion to make use of Aitia's 'electronic doubles' to discover brand new cancer medicines

.Finnish biotech Orion has actually snooped prospective in Aitia's "digital identical twin" technolo...

Windtree's surprise med brings up blood pressure in most up-to-date stage 2 win

.While Windtree Therapies has actually struggled to grow the monetary origins needed to have to surv...

2 cancer cells biotechs combine, creating international footprint

.OncoC4 is taking AcroImmune-- and its internal medical manufacturing capabilities-- under its own f...

Amgen files initial period 3 win for $400M eczema medication

.Amgen has actually shared (PDF) the first stage 3 records on its $400 thousand dermatitis medicatio...

Biogen, UCB document phase 3 lupus succeed after falling short earlier test

.Biogen and UCB's gamble on advancing right into phase 3 astride an unsuccessful study hopes to have...

Aptadir wishes brand new RNA inhibitors may reverse challenging cancers cells

.Italian biotech Aptadir Rehabs has introduced with the commitment that its pipe of preclinical RNA ...

Wave surfs DMD excellence to regulators' doors, sending out stock up

.Wave Lifestyle Sciences has satisfied its objective in a Duchenne muscle dystrophy (DMD) research, ...

Sanofi tweezes brand-new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer...

Achilles splashes tissue treatment program, bandages for discharges after skipping 'office stability' targets

.Achilles Rehabs has actually wrecked its own technique. The English biotech is quiting working on i...